cagrilintide and retatrutide together Clinical trials of subcutaneous tirzepatide, retatrutide, Retatrutide + Cagrilintide: The STRONGEST

For moderate IPTB, NAC oral dose (ACC long, 600 mg, Hexal), prepared by University Hospital of Nantes Pharmacy, was administrated at 3.6 g/d (80 mg/kg of body weight (BW)/d) in 6 doses from day 0 to day 7, followed by 1.8 g/d per os (40 mg/kg BW/d) from day 8 until 37th weeks of GA or delivery, whichever occurred first

Two-Year Outcomes of Transcatheter Tricuspid Valve Replacement For Severe Tricuspid Regurgitation: The TRISCEND II Randomized Trial

PMID: 2890903

8 GIPR deficiency in mice leads to impaired glucose tolerance with reduced cell function, 9 while GIP overexpression results in improved glucose tolerance, enhanced cell function, and resistance to highfat dietinduced obesity

Graham et al., 1978